Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1305
Selected: 0
NCT IDTitle
NCT00948688Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas
NCT03455764MCS110 With BRAF/MEK Inhibition in Patients With Melanoma
NCT03059485DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission
NCT03818087Elevate! : An Elderly Breast Cancer Cohort Study
NCT01534078Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma
NCT04572763Copanlisib Plus Venetoclax in R/R DLBCL
NCT04950608Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
NCT00165217Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma
NCT04339140Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer
NCT06208748SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST
NCT03692325Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia
NCT02375776Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention
NCT01004172Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases
NCT07220239Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
NCT00047294Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT06664151A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision
NCT02201212Everolimus for Cancer With TSC1 or TSC2 Mutation
NCT02641236Gut Decontamination In Pediatric Allogeneic Hematopoietic
NCT00880464Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast Cancer
NCT05292664Venetoclax Basket Trial for High Risk Hematologic Malignancies
NCT01838564The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms Technology
NCT00543114Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL
NCT01325506Effectiveness of Open and Robotic Prostatectomy
NCT00580333Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer
NCT02335671Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy
NCT01551693STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma
NCT05521178Cardiotoxicities in Patients Receiving BTKi
NCT03331406Physical Activity In Gastrointestinal Cancer
NCT00480506Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major
NCT01400685Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL
NCT06084234National Liver Cancer Screening Trial
NCT01600807OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas
NCT07227584ALL Backbone in AYAs
NCT01912963Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast Cancer
NCT01550458Safety Study of Mibefradil When Given Four Times a Day in Healthy Volunteers
NCT00806715Iron Overload in Stem Cell Transplant Recipients
NCT06488378Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
NCT06001749Psilocybin in Cancer Pain Study
NCT07499999Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer
NCT03361852Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma
NCT01958112GSK1120212+GSK2141795 for Cervical Cancer
NCT04030507Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
NCT07467772Ph 2 Elacestrant in ER Positive Uterine Sarcomas
NCT00782275Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
NCT04653246Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM
NCT04906902Acalabrutinib in CNSL
NCT05407441Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
NCT01562873Ruxolitinib in Patients With Breast Cancer
NCT00101075Title XELOX FOR SALIVARY GLAND CANCERS
NCT03850912Symptom Management Implementation of Patient Reported Outcomes in Oncology